| P2093 | author name string | Karen P Alexander | |
| | S Michael Gharacholou | |
| P2860 | cites work | Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes | Q22306397 |
| | Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 |
| | Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients | Q28193844 |
| | Frailty in older adults: evidence for a phenotype | Q28205094 |
| | Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study | Q28213764 |
| | MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 |
| | Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. | Q32069186 |
| | Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events | Q33151664 |
| | Ageism in cardiology | Q33776547 |
| | Representation of elderly persons and women in published randomized trials of acute coronary syndromes | Q34331421 |
| | ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th | Q34347047 |
| | Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease | Q35049811 |
| | Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). | Q35581538 |
| | Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report | Q35739002 |
| | The exclusion of the elderly and women from clinical trials in acute myocardial infarction | Q35765397 |
| | Clinical practice. Diastolic heart failure | Q35882182 |
| | The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 |
| | Management of drug therapy in the elderly | Q38662035 |
| | A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective | Q39508367 |
| | Predictors of delay in presentation to the ED in patients with suspected acute coronary syndromes | Q39666254 |
| | Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction | Q43623963 |
| | Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study | Q43859232 |
| | The prognostic importance of creatinine clearance after acute myocardial infarction | Q44031327 |
| | Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes | Q44108434 |
| | Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. | Q44420954 |
| | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Q44588075 |
| | The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes | Q45003891 |
| | Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin | Q45023381 |
| | Hypercoagulability in centenarians: the paradox of successful aging. | Q45869145 |
| | A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group | Q47303123 |
| | Heart failure and the elderly: disease diversity, data, and delivery of care | Q47723572 |
| | Are we biased in our approach to treating elderly patients with heart disease? | Q52863720 |
| | Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. | Q53371777 |
| | ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G | Q55889587 |
| | Unstable Angina : An Etiologic Approach to Management | Q56674423 |
| | Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials | Q56944618 |
| | Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies | Q57697531 |
| | The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community | Q61454238 |
| | Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study | Q70626892 |
| | Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo | Q72665772 |
| | Recent trends in hospital mortality of acute myocardial infarction--the Worcester Heart Attack Study. Have improvements been realized for all age groups? | Q72766048 |
| | Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack study | Q73214573 |
| | Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group | Q73217818 |
| | Thrombolytic therapy in the elderly | Q73365337 |
| | Age and outcome after acute coronary syndromes without persistent ST-segment elevation | Q73716497 |
| | Poor long-term survival after acute myocardial infarction among patients on long-term dialysis | Q77300271 |
| | Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) | Q77639025 |
| | Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative | Q80931335 |
| P433 | issue | 2 | |
| P304 | page(s) | 51-56 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Current heart failure reports | Q26842297 |
| P1476 | title | Issues with care in the elderly patient presenting with acute ischemia | |
| P478 | volume | 3 | |